The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

HCP Inc

NYSE: HCP
Last

(U.S.) $37.94

Today's change+0.43 +1.15%
Updated August 27 4:04 PM EDT. Delayed by at least 15 minutes.
 

HCP Inc

NYSE: HCP
Last

(U.S.) $37.94

Today's change+0.43 +1.15%
Updated August 27 4:04 PM EDT. Delayed by at least 15 minutes.

HCP Inc up (U.S.)$0.43

HCP Inc closed up Thursday by (U.S.)$0.43 or 1.15% to (U.S.)$37.94. Over the last five days, shares have lost 6.34% and sit 4.81% above their 52-week low. This security has underperformed the S&P 500 by 10.77% during the last year.

Key company metrics

  • Open(U.S.) $37.81
  • Previous close(U.S.) $37.51
  • High(U.S.) $38.29
  • Low(U.S.) $37.28
  • Bid / Ask(U.S.) $37.29 / (U.S.) $38.27
  • YTD % change-13.83%
  • Volume5,865,661
  • Average volume (10-day)5,013,341
  • Average volume (1-month)4,514,310
  • Average volume (3-month)3,571,875
  • 52-week range(U.S.) $36.20 to (U.S.) $49.61
  • Beta0.42
  • Trailing P/E47.53×
  • P/E 1 year forward19.54×
  • Forward PEG5.92×
  • Indicated annual dividend(U.S.) $2.26
  • Dividend yield5.96%
  • Trailing EPS(U.S.) $0.80
Updated August 27 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+15.34%

Based on its net profit margin of 15.34%, HCP Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.88%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue608611604597
Total other revenue--------
Total revenue608611604597
Gross profit471479473497
Total cost of revenue136132130100
Total operating expense349753271248
Selling / general / administrative29252025
Research & development--------
Depreciation / amortization120115116123
Interest expense (income), net operating--------
Unusual expense (income)634824--
Other operating expenses, total--------
Operating income259-142333349
Interest income (expense), net non-operating-119-117-115-111
Gain (loss) on sale of assets063--
Other--------
Income before tax151-251223241
Income after tax156-251225241
Income tax, total-50-30
Net income165-241197248
Total adjustments to net income0000
Net income before extra. items165-241197248
Minority interest-3-3-3-3
Equity in affiliates1214-2610
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items165-241196247
Inc. avail. to common incl. extra. items165-241196247
Diluted net income165-241196247
Dilution adjustment000--
Diluted weighted average shares462461460459
Diluted EPS excluding extraordinary itemsvalue per share0.36-0.520.430.54
Dividends per sharevalue per share0.570.570.550.55
Diluted normalized EPSvalue per share0.440.150.430.47